Teriparatide + Teriparatide + placebo
Phase 1Completed 0 watching 0 views this week๐ค Quiet
25
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug Safety
Conditions
Drug Safety
Trial Timeline
Jul 1, 2011 โ Aug 1, 2013
NCT ID
NCT02202603About Teriparatide + Teriparatide + placebo
Teriparatide + Teriparatide + placebo is a phase 1 stage product being developed by Entera Bio for Drug Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT02202603. Target conditions include Drug Safety.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02202603 | Phase 1 | Completed |
Competing Products
20 competing products in Drug Safety